SERA Company Profile and Key Details
Sera Prognostics, Inc.
SERA Stock Price Chart
Stock Price Today
Sera Prognostics, Inc. (SERA) stock declined over -3.61%, trading at $4.54 on NASDAQ, down from the previous close of $4.71. The stock opened at $4.73, fluctuating between $4.50 and $4.85 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Company Information
| Employees | 55 |
| Beta | 1.04 |
| Sales or Revenue | $306.00K |
| 5Y Sales Change% | 7.363% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
Frequently Asked Questions
Sera Prognostics, Inc. (NASDAQ: SERA) stock price is $4.54 in the last trading session. During the trading session, SERA stock reached the peak price of $4.85 while $4.50 was the lowest point it dropped to. The percentage change in SERA stock occurred in the recent session was -3.61% while the dollar amount for the price change in SERA stock was -$0.17.
The NASDAQ listed SERA is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector. Sera Prognostics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Michael R. Foley M.D.
Chief Medical Officer
Ms. Nadia F. Altomare
Chief Commercial Officer
Dr. Steven W. Graves
Co-Founder and Co-Chairman of The Scientific Advisory Board
Dr. Gregory C. Critchfield M.D., M.S.
Executive Director
Mr. Benjamin G. Jackson J.D.
Gen. Counsel
Dr. Paul Kearney Ph.D.
Chief Data Officer
Mr. Robert G. Harrison
Chief Information Officer
Dr. John J. Boniface Ph.D.
Chief Scientific Officer
Mr. Jay M. Moyes M.B.A., MBA
Chief Financial Officer
Dr. M. Sean Esplin M.D.
Co-Founder and Co-Chairman of Scientific Advisory Board
Ms. Evguenia Lindgardt M.B.A.
Interim Pres, Chief Executive Officer & Director
Mr. Austin Aerts
Chief Financial Officer??
SERA's closing price is 0.89% higher than its 52-week low of $4.50 where as its distance from 52-week high of $12.36 is -63.25%.
Number of SERA employees currently stands at 55.
Official Website of SERA is: https://seraprognostics.com
SERA could be contacted at phone 801 990 0520 and can also be accessed through its website. SERA operates from 2749 East Parleys Way, Salt Lake City, UT 84109, United States.
SERA stock volume for the day was 87.78K shares. The average number of SERA shares traded daily for last 3 months was 109.53K.
The market value of SERA currently stands at $148.93M with its latest stock price at $4.54 and 32.8M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com